Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 28, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- November 24, 2006: Transfer of 10,200 Ordinary Shares.
- November 27, 2006: Transfer of 75,781 Ordinary Shares.
These transactions were advised to the Company on November 27 and November 28, 2006, respectively.
Outlook, Risks, and Management Commentary
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees. No forward-looking guidance, risk factors, or unusual items are disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan 1991 during the reporting period (85,981 shares total).
- Confirm the specific dates of transfer (November 24 and November 27, 2006) versus the dates the Company was advised (November 27 and 28, 2006).
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for financial metrics.